University of Health Sciences Turkey, Experimental Medicine Research and Application Center, Uskudar, 34662, Istanbul, Turkey.
Department of Chemistry, Faculty of Science, Karatekin University, Çankırı, 18100, Turkey.
Chem Biol Interact. 2022 Jan 5;351:109742. doi: 10.1016/j.cbi.2021.109742. Epub 2021 Nov 11.
In this work, new thiosemicarbazides (ECA-1, ECA-2) and their Cu (II) complexes (ECA-1-Cu, ECA-2-Cu) were synthesized and their structures were characterized by H NMR, C NMR, FT-IR, LC-MS, UV-Vis, and thermogravimetric analysis methods. Also, the surface morphology of the all compounds were examined by SEM (Scanning Electron Microscope). In the second stage, in vitro antioxidant capacity of the obtained compounds was investigated. The evaluation of the antioxidant properties of both synthesized ligands and complexes in this study was carried out by DPPH and FRAP methods. According to the results, both complexes exhibited more antioxidant capacity than the corresponding ligands. When antioxidant effects are compared for DPPH (SC = 5.27 ± 0.05 μM) and for FRAP (7845.69 ± 16.75 mmolTE/g), compound ECA-2-Cu appears to have the best inhibition effect. The complexes were found non-electrolytic in nature with melting point of above 250 °C, and electronic spectra and magnetic behavior demonstrated that the complexes were found to be tetrahedral geometry. Further, in silico the ADMET properties which studies are a significant role in improving and predicting drug compounds were calculated using web-based platforms. The theoretical calculations were made using the method of Density Functional Theory (Frontier molecular orbital analyze and Nonlinear optical properties). Also, molecular docking studies were performed to evaluate the binding interactions between the ligand and complex compounds and Human Peroxiredoxin 2. Both in vitro and in silico results indicated that synthesized compounds could act as potent antioxidant agents.
在这项工作中,合成了新的硫代卡巴肼(ECA-1、ECA-2)及其铜(II)配合物(ECA-1-Cu、ECA-2-Cu),并通过 H NMR、C NMR、FT-IR、LC-MS、UV-Vis 和热重分析方法对其结构进行了表征。此外,还通过 SEM(扫描电子显微镜)检查了所有化合物的表面形态。在第二阶段,研究了所得到的化合物的体外抗氧化能力。本研究通过 DPPH 和 FRAP 方法评价了两种合成配体和配合物的抗氧化性能。结果表明,两种配合物的抗氧化能力均强于相应的配体。当比较 DPPH(SC=5.27±0.05μM)和 FRAP(7845.69±16.75mmolTE/g)的抗氧化作用时,化合物 ECA-2-Cu 的抑制效果最好。这些配合物是非电解质,熔点高于 250°C,电子光谱和磁行为表明这些配合物具有四面体几何形状。此外,还使用基于网络的平台计算了理论计算,以评估 ADMET 性质,这在改善和预测药物化合物方面具有重要作用。理论计算是使用密度泛函理论(前沿分子轨道分析和非线性光学性质)方法进行的。还进行了分子对接研究,以评估配体和配合物与人类过氧化物酶 2 之间的结合相互作用。体外和体内结果均表明,合成的化合物可以作为有效的抗氧化剂。